• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.34%

    DepoMed Inc. (DEPO)

    -NasdaqGS
    20.64 Down 0.20(0.96%) 4:00PM EDT
    |After Hours : 20.64 0.00 (0.00%) 5:30PM EDT
    Add to Portfolio
    Prev Close:20.84
    Open:20.60
    Bid:20.00 x 100
    Ask:21.63 x 200
    1y Target Est:27.43
    Beta:1.42
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:20.37 - 21.05
    52wk Range:9.85 - 28.16
    Volume:853,844
    Avg Vol (3m):1,570,970
    Market Cap:1.24B
    P/E (ttm):12.88
    EPS (ttm):1.60
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DEPODown 0.96%1.24B
    MRKDown 0.21%162.59B
    PFEDown 0.36%204.74B
    TEVAUp 0.16%52.29B

    Key Statistics

    Forward P/E (1 yr):17.20
    P/S (ttm):3.61
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.29
    Quarterly EPS Est (Jun-15) :-0.03
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):2.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAM... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback